Biosynthesis of Purine Nucleotide biosynthesis is a crucial biochemical process that generates the building blocks of DNA and RNA. It involves the synthesis of purine and pyrimidine nucleotides through complex pathways that ensure a balanced supply of these essential molecules for cellular functions.
Biosynthesis of Purine Nucleotide
Purine nucleotides (adenine and guanine) are synthesized via a multi-step pathway known as the de novo synthesis pathway. This process occurs mainly in the cytoplasm of liver cells.
De Novo Purine Synthesis
1. Starting Material: The pathway begins with ribose-5-phosphate, which is derived from the pentose phosphate pathway.
2. Formation of PRPP:
Enzyme: PRPP synthetase.
Reaction: Ribose-5-phosphate is converted to 5-phosphoribosyl-1-pyrophosphate (PRPP) using ATP.
3. Synthesis of Inosine Monophosphate (IMP):
Enzyme: Amidophosphoribosyltransferase.
Reaction: PRPP reacts with glutamine to form 5-phosphoribosylamine.
Subsequent Steps: Through a series of reactions involving glycine, formate (as formyl-tetrahydrofolate), glutamine, ATP, and aspartate, the purine ring is built step-by-step.
Key Intermediates: Glycinamide ribonucleotide (GAR), formylglycinamide ribonucleotide (FGAR), 5-aminoimidazole ribonucleotide (AIR), carboxyaminoimidazole ribonucleotide (CAIR), and inosine monophosphate (IMP).
4. Conversion of IMP to AMP and GMP:
AMP Synthesis:
Enzyme: Adenylosuccinate synthetase.
Reaction: IMP reacts with aspartate and GTP to form adenylosuccinate, which is then converted to AMP by adenylosuccinate lyase.
GMP Synthesis:
Enzyme: IMP dehydrogenase.
Reaction: IMP is oxidized to xanthosine monophosphate (XMP) using NAD+.
Enzyme: GMP synthetase.
Reaction: XMP reacts with glutamine and ATP to form GMP.
Salvage Pathways
1. Recycling of Purine Bases:
Adenine Phosphoribosyltransferase (APRT):
Converts adenine to AMP using PRPP.
Hypoxanthine-Guanine Phosphoribosyltransferase (HGPRT):
Converts hypoxanthine to IMP and guanine to GMP using PRPP.
Pyrimidine Nucleotide Biosynthesis
Pyrimidine nucleotides (cytosine, thymine, and uracil) are synthesized through a pathway distinct from purine biosynthesis, with the pyrimidine ring being synthesized before it is attached to the ribose-phosphate.
De Novo Pyrimidine Synthesis
1. Formation of Carbamoyl Phosphate:
Enzyme: Carbamoyl phosphate synthetase II (CPS II).
Reaction: Synthesis of carbamoyl phosphate from glutamine, CO2, and ATP in the cytoplasm.
2. Formation of Carbamoyl Aspartate:
Enzyme: Aspartate transcarbamoylase (ATCase).
Reaction: Carbamoyl phosphate reacts with aspartate to form carbamoyl aspartate.
3. Formation of Dihydroorotate:
Enzyme: Dihydroorotase.
Reaction: Carbamoyl aspartate is cyclized to form dihydroorotate.
4. Oxidation to Orotate:
Enzyme: Dihydroorotate dehydrogenase.
Reaction: Dihydroorotate is oxidized to orotate.
5. Formation of Orotidine Monophosphate (OMP):
Enzyme: Orotate phosphoribosyltransferase.
Reaction: Orotate reacts with PRPP to form OMP.
6. Formation of Uridine Monophosphate (UMP):
Enzyme: Orotidylate decarboxylase.
Reaction: OMP is decarboxylated to form UMP.
7. Conversion of UMP to Other Pyrimidines:
UMP to CTP:
Enzyme: CTP synthetase.
Reaction: UMP is first phosphorylated to UDP and then to UTP, which is then converted to CTP by reacting with glutamine.
UMP to dTMP:
Enzyme: Thymidylate synthase.
Reaction: UMP is converted to dTMP (thymidine monophosphate) by first being reduced to dUMP (deoxyuridine monophosphate), which then undergoes methylation using methylene tetrahydrofolate.
Salvage Pathways
1. Recycling of Pyrimidine Bases:
Uracil Phosphoribosyltransferase (UPRT): Converts uracil to UMP using PRPP.
Thymidine Kinase (TK): Converts thymidine to TMP (thymidine monophosphate).
Regulation of Nucleotide Biosynthesis
1. Feedback Inhibition:
Purine Biosynthesis: AMP and GMP feedback inhibit PRPP synthetase and amidophosphoribosyltransferase.
Pyrimidine Biosynthesis: UMP and UDP inhibit carbamoyl phosphate synthetase II (CPS II).
2. Balancing Nucleotide Pools:
Cross-Regulation: GTP is used in the synthesis of AMP, and ATP is used in the synthesis of GMP to balance the purine nucleotide pools.
Enzyme Specificity: Different enzymes and pathways ensure a balanced supply of nucleotides according to the cellular needs.
Importance and Clinical Relevance
1. Cell Proliferation: Nucleotide biosynthesis is critical for DNA replication and RNA synthesis, essential for cell division and growth.
2. Cancer Therapy: Many chemotherapeutic agents target nucleotide biosynthesis enzymes to inhibit the rapid proliferation of cancer cells.
3. Genetic Disorders: Deficiencies in enzymes involved in nucleotide metabolism can lead to disorders such as Lesch-Nyhan syndrome (HGPRT deficiency) and orotic aciduria (deficiency in orotate phosphoribosyltransferase or orotidylate decarboxylase).
Understanding the biosynthesis of purine and pyrimidine nucleotides provides insight into fundamental cellular processes and aids in the development of therapeutic strategies for various diseases.
Visit to: Pharmacareerinsider.com
